(2S,3S)-3-Methylpent-4-en-2-ol, 97%, 1g

rel-(1R,2S,5S)-METHYL 3-AZABICYCLO[3.1.0]HEXANE-2-CARBOXYLATE HCL, 95.0%, 250mg

Methyl 3-(Methylamino)but-2-enoate, 97.0%, 1g

1,4-dioxane, min 99,5 %, pour la synthèse, stabilisé, 2,5 l, emballage en verre

2-Hydroxy-4,5-dimethoxybenzaldehyde, 97.0%, 5g

3,3,7-Trimethylindolin-2-one, 97%, 5g

N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-ylamino)phenyl)acetamide, 97%, 50mg

(R)-TERT-BUTYL (1,3-DIHYDROXY-3-METHYLBUTAN-2-YL)CARBAMATE, 95.0%, 2g

Abexinostat, 98.61%, 25mg

1-(2-Bromoethoxy)-4-chlorobenzene, 95.0%, 25g

2,5-Dimethyl-4-phenyl-2H-pyrazol-3-ylamine, 95.0%, 25g

N-((1H-BENZO[D][1,2,3]TRIAZOL-1-YL)METHYL)-4-(BENZYLOXY)-2-NITROANILINE, 95.0%, 250mg

Dolasetron Mesylate Monohydrate>98.0%(HPLC)50mg